in the news articles ↓

 

reminder: lindasy.com is closing down

There are just a couple of days left now, vita-oil and the oatmeal cleanser are sold out, but ZincO cream still has some stocks. Just in case anyone has missed the email over at rosacea-support; Linda Sy has been in contact to say that she is retiring and thus her web site and business is closing. Anyone who wants to stock …

 

Allergan buys Aczone, has plans for rosacea targeting ?

OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m. From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5% …

 

Google Health Launches, rosacea is included as a condition

Google has been talking for a while about their push into health services. One of their stated features of Google Health is "Learn about health issues and find helpful resources: Review trusted information on diseases and conditions and learn about possible medication interactions and other topics to talk your doctors about." As part of their new offering Google Health has created some Condition References. …

 

Oracea approved for much of Europe

In the news this week is an announcement that Oracea is on its way to being approved for sale in Germany, UK, Italy, Austria, Ireland, Sweden, Finland, Luxembourg and The Netherlands. European Regulatory Authority (EMEA) Recommends Granting Of Marketing Authorization For MediGene’s Drug Oracea MediGene AG announced that the European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) has concluded …

 

Welcome to New York Times readers

If you are visiting rosacea-support.org today because of the article in SKIN DEEP - In a Perfect World, Rosacea Remains a Problem, WELCOME !

Rosacea is a common, progressive and often misunderstood disease. We hope that you find some useful resources on this site.

On this site you will find hundreds of news and research items. Use the Articles links on the left hand side to …